Preserving Clinical Trial Integrity During the Coronavirus Pandemic
Author:
Affiliation:
1. Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
2. Deputy Editor, JAMA
3. Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jama/articlepdf/2763819/jama_mcdermott_2020_vp_200061.pdf
Reference3 articles.
1. Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial.;Pahor;JAMA,2014
2. Trends, charts, and maps. ClinicalTrials.gov. Accessed March 16, 2020. https://clinicaltrials.gov/ct2/resources/trends
3. FDA guidance on conduct of clinical trials of medical products during COVID-19 pandemic: guidance for industry, investigators, and institutional review boards. US Food and Drug Administration. Published March 2020. Accessed March 18, 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-pandemic
Cited by 156 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Platelet-Rich Plasma Injections for the Treatment of Ankle Osteoarthritis: Response;The American Journal of Sports Medicine;2024-02
2. A qualitative study on the impacts of COVID-19 on the delivery of randomised controlled trials evaluating lay-delivered psychological interventions in five countries;SSM - Mental Health;2023-12
3. Developing resilient clinical trials: Lessons learned from rolling out the Get Back to Healthy trial during a pandemic;Contemporary Clinical Trials;2023-10
4. Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER;American Heart Journal;2023-09
5. Results of a 12-Month Randomized Controlled Trial Testing the Efficacy of the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB) for People Post Stroke (GLB-CVA);Annals of Behavioral Medicine;2023-08-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3